|
Volumn 20, Issue 4, 1982, Pages 401-403
|
Bacillus Calmette-Guerin (BCG) adjuvant therapy in stage D prostate cancer
a,b a,b a,b a,b a,b |
Author keywords
[No Author keywords available]
|
Indexed keywords
ADJUVANT;
BCG VACCINE;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FLUOROURACIL;
CANCER IMMUNOTHERAPY;
CLINICAL TRIAL;
CONTROLLED STUDY;
HUMAN;
MAJOR CLINICAL STUDY;
MALE GENITAL SYSTEM;
PROSTATE CANCER;
RANDOMIZED CONTROLLED TRIAL;
THERAPY;
ADENOCARCINOMA;
AGED;
BCG VACCINE;
CLINICAL TRIALS;
ESTROGENS;
HUMANS;
MALE;
NEOPLASM STAGING;
PROGNOSIS;
PROSPECTIVE STUDIES;
PROSTATIC NEOPLASMS;
QUALITY OF LIFE;
RANDOM ALLOCATION;
|
EID: 0019942973
PISSN: 00904295
EISSN: 15279995
Source Type: Journal
DOI: 10.1016/0090-4295(82)90464-2 Document Type: Article |
Times cited : (21)
|
References (16)
|